PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2226

  1. 339 Posts.
    lightbulb Created with Sketch. 130
    Something for you all to sink your teeth into.

    A great interview with Orthopaedic Surgeon Dr Elizabeth Yurth discussing OA treatments. At about 18.40min into the interview, they start to discuss pentosan including touching on Paradigm's work. She currently prescribes iPPS to her patients and is quite enthusiastic about it. Dr.Yurth even goes as far as believing it's potentially a CURE for OA. Also mentioned numerous other ailments that Pentosan could be used for.

    Can't help but feel like we are on a winner.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.